slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 27,901-27,930
Pages 1,437
Rows per page 30
Arc
27,901-27,930 of 43,093
10
The table uses blue highlighting to emphasize the higher severity metrics in the EBO Ph 2 group.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
11
LSM = Least squares mean. PRO = Patient-Reported Outcome. The slide highlights alignment with FDA guidance for primary endpoints in NTM trials.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
12
The chart highlights a statistically significant improvement (p=0.036) at month 6.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
13
The chart shows a longitudinal comparison of two treatment groups over 6 months. The p-value of 0.043 indicates nominal statistical significance for the difference in mean change from baseline.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
14
The slide presents TEAE (Treatment-emergent adverse events) and SAE (Serious adverse events) data.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
Includes a map showing global distribution and a specific callout for US endemicity.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a central hub-and-spoke style diagram to connect funding sources with market potential.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
33
AN2 Therapeutics | Investor Presentation Deck | 36 slidesAN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Team1 hit
34
AN2 Therapeutics | Investor Presentation Deck | 36 slidesAN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Team1 hit
03
The chart highlights the components of total outstanding shares (Common Stock vs Equity-based Awards) and the resulting 1.4% dilution.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Problem1 hit
04
The chart uses a cohort analysis framework to visualize customer lifetime value progression over time.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Problem1 hit
05
The slide includes specific disclaimers regarding the Farfetch acquisition and FX-neutral calculations.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Problem1 hit
06
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Solution1 hit
07
The chart uses a bar chart to show absolute profit and a dot/line indicator for margin percentages.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Solution1 hit
08
The chart includes a break in the Q4 23 bar to accommodate the large $1.0B value. Footnotes explain non-recurring tax adjustments and specific exclusions for Q4 2024.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses two bar charts to contrast Gross Profit growth against a decline in Net Income, with detailed footnotes explaining the impact of Farfetch and fire insurance gains/losses.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Solution1 hit
10
Includes specific callouts for Q4 24 excluding Farfetch impact.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Solution1 hit
11
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
12
The slide explains the decline as being due to non-recurring working capital benefits in the prior year.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
13
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
14
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
15
The chart displays quarterly active customer counts, highlighting a 10% year-over-year increase.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
16
Includes Farfetch revenue contribution as noted in the footer.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
17
The slide uses a combination of bar charts for absolute dollar values and dot markers for margin percentages.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
18
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Financials1 hit
19
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Why Now1 hit
20
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Why Now1 hit
03
This is a dense financial data table (supplementary material).Deutsche Bank | Results Presentation Deck | 28 slides · Deutsche Bank
Conference presentation Investor relations Beat · Financials1 hit
04
Includes performance measures and ratios at the bottom.Deutsche Bank | Results Presentation Deck | 28 slides · Deutsche Bank
Conference presentation Investor relations Beat · Financials1 hit
05
Financial data table showing asset categories including cash, loans, and derivatives.Deutsche Bank | Results Presentation Deck | 28 slides · Deutsche Bank
Conference presentation Investor relations Beat · Financials1 hit